Drug Profile
Cefazolin - Celerity Pharmaceuticals
Alternative Names: Cefazolin in plastic container - Baxter/Celerity; Cefazolin injection in GALAXY containerLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Celerity Pharmaceuticals
- Developer Baxter Healthcare Corporation; Celerity Pharmaceuticals
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors; Penicillin-binding protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bacterial infections
Most Recent Events
- 30 Aug 2022 Baxter Healthcare completes a phase I trial for Bacterial infections (Prevention, for perioperative prophylaxis) in USA (IV) (NCT05309304)
- 14 Feb 2022 Baxter Healthcare initiates a Phase-I clinical trial in Bacterial infections (Prevention, for perioperative prophylaxis) in USA (IV) (NCT05309304)
- 27 Oct 2015 Registered for Bacterial infections (Prevention) in USA (IV)